Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
Plos One|April 1, 2016
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment OptionsGiulio Disanto, Pascal Benkert, Johannes Lorscheider, et al.
Trials|September 11, 2024
MultiSCRIPT-Cycle 1-a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trialPerrine Janiaud, Chiara Zecca, Anke Salmen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2018
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosisXavier Montalban, Ralf Gold, Alan J Thompson, et al.
The Lancet. Neurology|February 19, 2022
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation studyPascal Benkert, Stephanie Meier, Sabine Schaedelin, et al.
Nature Reviews. Neurology|January 15, 2025
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMTPaolo A Muraro, Alice Mariottini, Raffaella Greco, et al.
Plos One|February 8, 2017
Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test resultsJenny Link, Ryan Ramanujam, Michael Auer, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 28, 2025
Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS CohortGiulio Disanto, Sabine Schaedelin, Johanna Oechtering, et al.
CNS Neuroscience & Therapeutics|April 24, 2013
Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS)Jana Lizrova Preiningerova, Ulf Baumhackl, Tunde Csepany, et al.
Science Translational Medicine|July 22, 2026
Anti-CD20 B cell depletion is associated with elevated mucosal-originating circulating regulatory IgA B cells in multiple sclerosisTradite Neziraj, Elisabeth Pössnecker, Angela A Wang, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 20, 2024
Neurofilament Light Chain as a Discriminator of Disease Activity Status in MOG Antibody-Associated DiseaseAna Beatriz Ayroza Galvão Ribeiro Gomes, Su-Hyun Kim, Roxanne Pretzsch, et al.
Pageof 17